Skip to main content
Log in

Echocardiographic outcomes of self-expandable CoreValve versus balloon-expandable Edwards SAPIEN XT valves: the comparison of two bioprosthesis implanted in a single centre

  • Original Paper
  • Published:
The International Journal of Cardiovascular Imaging Aims and scope Submit manuscript

Abstract

Transcatheter aortic valve implantation (TAVI) with self-expandable Medtronic CoreValve (MCV; Medtronic, Minneapolis, MN) or balloon-expandable Edwards SAPIEN XT valve (ESV; Edwards Lifesciences, Irvine, CA) has been widely used for treatment of high-risk patients with severe aortic stenosis (AS). There is limited data comparing the long-term hemodynamic performance of these two valves. Therefore, this study aimed to compare the short and long-term hemodynamic performance of TAVI with either MCV or ESV. A total of 78 patients who underwent TAVI in our center between June 01, 2012 and January 01, 2014 were enrolled in this retrospective study. For each of the patients we recorded the preprocedural echocardiographic data as well as the post-TAVI echocardiographic outcomes at day one, 6 months and 1 year. The MCV group had lower transaortic gradients than the ESV group, with respect to both maximum (13.4 ± 5.8 vs 18.7 ± 8.1 mmHg, p = 0.001) and mean values (6.5 ± 3.2 vs 9.4 ± 4.3 mmHg, p < 0.001) at post-TAVI day one. These values continued to be significantly lower in the MCV group during post-TAVI 6 months (p < 0.001) and post-TAVI 1 year follow-up (p < 0.05). A paravalvular leak (PVL, grade ≥2) was observed in 6.4 % of patients after TAVI; however, this value decreased over time, and there was no significant difference between the MVC and ESV groups (8.2 vs 3.4 %, p = 0.646). The MCV bioprosthesis was associated with lower transaortic gradients than those of the ESV throughout 1 year of follow-up. The incidence of PVL grade ≥2 in MCV and ESV was comparable.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Leon MB, Smith CR, Mack M et al; PARTNER Trial Investigators (2010) Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 363:1597–1607

    Article  CAS  PubMed  Google Scholar 

  2. Smith CR, Leon MB, Mack MJ et al; PARTNER Trial Investigators (2011) Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med 364:2187–2198

    Article  CAS  PubMed  Google Scholar 

  3. Rodés-Cabau J (2011) Transcatheter aortic valve implantation: current and future approaches. Nat Rev Cardiol 9:15–29

    Article  PubMed  Google Scholar 

  4. Grube E, Schuler G, Buellesfeld L et al (2007) Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self-expanding CoreValve prosthesis: device success and 30-day clinical outcome. J Am Coll Cardiol 50:69–76

    Article  PubMed  Google Scholar 

  5. Grube E, Buellesfeld L, Mueller R et al (2008) Progress and current status of percutaneous aortic valve replacement: results of three device generations of the CoreValve revalving system. Circ Cardiovasc Interv 1:167–175

    Article  PubMed  Google Scholar 

  6. Stokłosa P, Szymański P, Dąbrowski M et al (2015) The impact of transcatheter aortic valve implantation on left ventricular performance and wall thickness––single-centre experience. Postepy Kardiol Interwencyjnej 11:37–43

    PubMed  PubMed Central  Google Scholar 

  7. Moat NE, Ludman P, de Belder MA et al (2011) Long-term outcomes after transcatheter aortic valve implantation in high-risk patients with severe aortic stenosis: the UK TAVI (United Kingdom transcatheter aortic valve implantation) registry. J Am Coll Cardiol 58:2130–2138

    Article  PubMed  Google Scholar 

  8. Gilard M, Eltchaninoff H, Iung B et al; FRANCE 2 Investigators (2012) Registry of transcatheter aortic-valve implantation in high-risk patients. N Engl J Med 366:1705–1715

    Article  CAS  PubMed  Google Scholar 

  9. Nombela-Franco L, Ruel M, Radhakrishnan S et al (2013) Comparison of hemodynamic performance of self-expandable CoreValve vs balloon-expandable Edwards SAPIEN aortic valves inserted by catheter for aortic stenosis. Am J Cardiol 111:1026–1033

    Article  PubMed  Google Scholar 

  10. Abdel-Wahab M, Comberg T, Büttner HJ et al; Segeberg-Krozingen TAVI Registry (2014) Aortic regurgitation after transcatheter aortic valve implantation with balloon- and self-expandable prostheses: a pooled analysis from a 2-center experience. JACC Cardiovasc Interv 7:284–292

    Article  PubMed  Google Scholar 

  11. Chang HH, Chen IM, Chen PL, Hsu TL, Lin SM, Chen YH (2015) Comparison of balloon-expandable valves versus self-expandable valves in high-risk patients undergoing transcatheter aortic valve replacement for severe aortic stenosis. J Chin Med Assoc 78:331–338

    Article  PubMed  Google Scholar 

  12. Kasel AM, Cassese S, Ischinger T et al (2014) A prospective, non-randomized comparison of SAPIEN XT and CoreValve implantation in two sequential cohorts of patients with severe aortic stenosis. Am J Cardiovasc Dis 4:87–99

    PubMed  PubMed Central  Google Scholar 

  13. Godino C, Maisano F, Montorfano M et al (2010) Outcomes after transcatheter aortic valve implantation with both Edwards-SAPIEN and CoreValve devices in a single center: the Milan experience. JACC Cardiovasc Interv 3:1110–1121

    Article  PubMed  Google Scholar 

  14. Vahanian A, Alfieri O, Andreotti F et al (2012) Guidelines on the management of valvular heart disease (version 2012). Eur Heart J 33:2451–2496

    Article  PubMed  Google Scholar 

  15. Kasel AM, Cassese S, Bleiziffer S et al (2013) Standardized imaging for aortic annular sizing: implications for transcatheter valve selection. JACC Cardiovasc Imaging 6:249–262

    Article  PubMed  Google Scholar 

  16. Evangelista A, Flachskampf F, Lancellotti P et al (2008) European Association of Echocardiography recommendations for standardization of performance, digital storage and reporting of echocardiographic studies. Eur J Echocardiogr 9:438–448

    Article  PubMed  Google Scholar 

  17. Hahn RT, Abraham T, Adams MS et al (2013) Guidelines for performing a comprehensive transesophageal echocardiographic examination: recommendations from the American Society of Echocardiography and the Society of Cardiovascular Anesthesiologists. J Am Soc Echocardiogr 26:921–964

    Article  PubMed  Google Scholar 

  18. Clavel MA, Rodés-Cabau J, Dumont E et al (2011) Validation and characterization of transcatheter aortic valve effective orifice area measured by Doppler echocardiography. JACC Cardiovasc Imaging 4:1053–1062

    Article  PubMed  Google Scholar 

  19. Zamorano JL, Badano LP, Bruce C et al (2011) EAE/ASE recommendations for the use of echocardiography in new transcatheter interventions for valvular heart disease. J Am Soc Echocardiogr 24:937–965

    Article  PubMed  Google Scholar 

  20. Pibarot P, Dumesnil JG (2012) Doppler echocardiographic evaluation of prosthetic valve function. Heart 98:69–78

    Article  PubMed  Google Scholar 

  21. Zoghbi WA, Chambers JB, Dumesnil JG et al (2009) Recommendations for evaluation of prosthetic valves with echocardiography and Doppler ultrasound. J Am Soc Echocardiogr 22:975–1014

    Article  PubMed  Google Scholar 

  22. Spethmann S, Dreger H, Schattke S et al (2012) Doppler haemodynamics and effective orifice areas of Edwards SAPIEN and CoreValve transcatheter aortic valves. Eur Heart J Cardiovasc Imaging 13:690–696

    Article  PubMed  Google Scholar 

  23. Tanrıverdi Z, Dursun H, Kaya D (2015) Comparison of echocardiographic results of CoreValve versus Edwards SAPIEN valves in patients with bicuspid aortic valve. Catheter Cardiovasc Interv. doi:10.1002/ccd.26052

    PubMed  Google Scholar 

  24. Athappan G, Patvardhan E, Tuzcu EM et al (2013) Incidence, predictors, and outcomes of aortic regurgitation after transcatheter aortic valve replacement: meta-analysis and systematic review of literature. J Am Coll Cardiol 61:1585–1595

    Article  PubMed  Google Scholar 

  25. Généreux P, Head SJ, Wood DA et al (2012) Transcatheter aortic valve implantation: 10-year anniversary part II: clinical implications. Eur Heart J 33:2399–2402

    Article  PubMed  Google Scholar 

  26. Hahn RT, Kodali S, Généreux P et al (2014) Paravalvular regurgitation following transcutaneous aortic valve replacement: predictors and clinical significance. Curr Cardiol Rep 16:475

    Article  PubMed  Google Scholar 

  27. Lerakis S, Hayek SS, Douglas PS (2013) Paravalvular aortic leak after transcatheter aortic valve replacement: current knowledge. Circulation 127:397–407

    Article  PubMed  Google Scholar 

  28. Dvir D, Barbash IM, Ben-Dor I et al (2013) Paravalvular regurgitation after transcatheter aortic valve replacement: diagnosis, clinical outcome, preventive and therapeutic strategies. Cardiovasc Revasc Med 14:174–181

    Article  PubMed  Google Scholar 

  29. Abdel-Wahab M, Mehilli J, Frerker C et al; CHOICE investigators (2014) Comparison of balloon-expandable vs self-expandable valves in patients undergoing transcatheter aortic valve replacement: the CHOICE randomized clinical trial. JAMA 311:1503–1514

    Article  PubMed  Google Scholar 

  30. O’Sullivan KE, Gough A, Segurado R et al (2014) Is valve choice a significant determinant of paravalvular leak post-transcatheter aortic valve implantation? A systematic review and meta-analysis. Eur J Cardiothorac Surg 45:826–833

    Article  PubMed  Google Scholar 

  31. Zegdi R, Lecuyer L, Achouh P et al (2010) Increased radial force improves stent deployment in tricuspid but not in bicuspid stenotic native aortic valves. Ann Thorac Surg 89:768–772

    Article  PubMed  Google Scholar 

  32. Tzamtzis S, Viquerat J, Yap J et al (2013) Numerical analysis of the radial force produced by the Medtronic-CoreValve and Edwards-SAPIEN after transcatheter aortic valve implantation (TAVI). Med Eng Phys 35:125–130

    Article  CAS  PubMed  Google Scholar 

  33. Jilaihawi H, Chin D, Spyt T et al (2010) Prosthesis-patient mismatch after transcatheter aortic valve implantation with the Medtronic CoreValve bioprosthesis. Eur Heart J 31:857–864

    Article  PubMed  Google Scholar 

  34. Ali OF, Schultz C, Jabbour A et al (2015) Predictors of paravalvular aortic regurgitation following self-expanding Medtronic CoreValve implantation: the role of annulus size, degree of calcification, and balloon size during pre-implantation valvuloplasty and implant depth. Int J Cardiol 179:539–545

    Article  CAS  PubMed  Google Scholar 

  35. Abdel-Wahab M, Zahn R, Horack M et al (2011) Aortic regurgitation after transcatheter aortic valve implantation: incidence and early outcome. Results from the German transcatheter aortic valve interventions registry. Heart 97:899–906

    Article  PubMed  Google Scholar 

  36. Tagaki K, Latib A, Al-Lamee R et al (2011) Predictors of moderate-to-severe paravalvular aortic regurgitation immediately after CoreValve implantation and the impact of postdilatation. Catheter Cardiovasc Interv 78:432–443

    Google Scholar 

  37. Bleiziffer S, Mazzitelli D, Opitz A et al (2012) Beyond the short-term: clinical outcome and valve performance 2 years after transcatheter aortic valve implantation in 227 patients. J Thorac Cardiovasc Surg 143:310–317

    Article  PubMed  Google Scholar 

  38. Kodali SK, Williams MR, Smith CR et al (2012) Two-year outcomes after transcatheter or surgical aortic valve replacement. N Engl J Med 366:1686–1695

    Article  CAS  PubMed  Google Scholar 

  39. Kapadia SR, Tuzcu EM, Makkar RR et al (2014) Long-term outcomes of inoperable patients with aortic stenosis randomly assigned to transcatheter aortic valve replacement or standard therapy. Circulation 130:1483–1492

    Article  CAS  PubMed  Google Scholar 

  40. Gurvitch R, Webb JG, Yuan R et al (2011) Aortic annulus diameter determination by multidetector computed tomogra-phy: reproducibility applicability and implications for transcatheter aortic valve implantation. JACC Cardiovasc Interv 4:1235–1245

    Article  PubMed  Google Scholar 

  41. Toggweiler S, Humphries KH, Lee M et al (2013) 5-year outcome after transcatheter aortic valve implantation. J Am Coll Cardiol 61:413–419

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Zulkif Tanriverdi.

Ethics declarations

Conflict of interest

Dr Dayimi Kaya is a clinical proctor for Medtronic Inc.

Informed consent

The Institutional Review Board granted approval of the study design and waived informed consent since solely data obtained in the context of clinical care is utilized.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kaya, D., Tanriverdi, Z., Dursun, H. et al. Echocardiographic outcomes of self-expandable CoreValve versus balloon-expandable Edwards SAPIEN XT valves: the comparison of two bioprosthesis implanted in a single centre. Int J Cardiovasc Imaging 32, 1371–1378 (2016). https://doi.org/10.1007/s10554-016-0924-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10554-016-0924-y

Keywords

Navigation